Kodiak Sciences Inc. is developing therapeutics for MESI patients and presented Phase 1b APEX data at scientific meetings in France and Chicago.
4 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kodiak Sciences Inc. is developing therapeutics for MESI patients and presented Phase 1b APEX data at scientific meetings in France and Chicago.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Tectonic is running the APEX clinical trial.Sub-event
Kodiak presented Phase 1b APEX data on MESI therapeutics at scientific congresses.1 source
- Kodiak announced it will present data on its MESI treatment at a congress in Rio de Janeiro.
Keep exploring
The entities involved
-
Kodiak Sciences Inc.
biotech company
-
APEX
consulting and engineering services
- SpaceX, APEX, and Elveo Mobile have partnered to advance basic texting capabilities toward 5G-type connectivity using dedicated satellite production.
- A new national support network has formed, involving centers in Southampton, Fareham, and Plymouth, to support operational readiness and autonomous ocean sensing technologies.
-
MESI
Nothing else this week.
Coverage
Newest first; wire copies grouped- PR NewswireKodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI) PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ --
- PR NewswireKodiak Sciences to Present at American Chemical Society Fall 2025 PALO ALTO, Calif., Aug. 19, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology com
- PR NewswireKodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results PALO ALTO, Calif., Aug. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported rece
- Unknown outlet